Ponce Financial Group Inc
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
PDLB$21.95-0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Financial Condition (Unaudited)
March 31, 2025 and December 31, 2024
| March 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| (unaudited) | ||
| ASSETS | ||
| Cash and due from banks: | ||
| Cash | $32,113 | $35,478 |
| Interest-bearing deposits | 97,780 | 104,361 |
| Total cash and cash equivalents | 129,893 | 139,839 |
| Available-for-sale securities, at fair value (Note 3) | 103,570 | 104,970 |
| Held-to-maturity securities, net of allowance for credit losses of $213 at March 31, 2025 and $216 at December 31, 2024; at amortized cost (fair value 2025 $349,518; 2024 $355,294) (Note 3) | 358,024 | 367,938 |
| Placement with banks | 249 | 249 |
| Mortgage loans held for sale, at fair value (Note 4) | 8,567 | 10,736 |
| Loans receivable, net of allowance for credit losses of $22,974 at March 31, 2025 and $22,502 at December 31, 2024 (Note 5) | 2,370,931 | 2,286,599 |
| Accrued interest receivable | 19,008 | 17,771 |
| Premises and equipment, net | 16,417 | 16,794 |
| Right of use assets (Note 6) | 29,496 | 29,093 |
| Federal Home Loan Bank of New York (FHLBNY) stock, at cost | 25,807 | 29,182 |
| Deferred tax assets | 11,629 | 12,074 |
| Other assets | 16,245 | 24,693 |
| Total assets | $3,089,836 | $3,039,938 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Liabilities: | ||
| Deposits (Note 7) | $2,004,947 | $1,884,864 |
| Operating lease liabilities | 31,126 | 30,696 |
| Accrued interest payable | 4,628 | 3,712 |
| Advance payments by borrowers for taxes and insurance | 12,901 | 10,349 |
| Borrowings (Note 8) | 521,100 | 596,100 |
| Other liabilities | 1,248 | 8,717 |
| Total liabilities | 2,575,950 | 2,534,438 |
| Commitments and contingencies (Note 10) | ||
| Stockholders' Equity: | ||
| Preferred stock, $0.01 par value; 100,000,000 shares authorized, 225,000 shares issued and outstanding as of March 31, 2025 and as of December 31, 2024. | 225,000 | 225,000 |
| Common stock, $0.01 par value; 200,000,000 shares authorized; 24,886,711 shares issued at both March 31, 2025 and December 31, 2024; 23,966,191 shares outstanding as of March 31, 2025 and 23,961,214 shares outstanding as of December 31, 2024 | 249 | 249 |
| Treasury stock, at cost; 920,520 shares as of March 31, 2025 and 925,497 shares as of December 31, 2024 | (7,641) | (7,707) |
| Additional paid-in-capital | 207,888 | 207,319 |
| Retained earnings | 113,432 | 107,754 |
| Accumulated other comprehensive loss (Note 13) | (13,515) | (15,297) |
| Unearned compensation ─ ESOP; 1,268,552 shares as of March 31, 2025 and 1,301,988 shares as of December 31, 2024 | (11,527) | (11,818) |
| Total stockholders' equity | 513,886 | 505,500 |
| Total liabilities and stockholders' equity | $3,089,836 | $3,039,938 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.